Proactive Investors - Run By Investors For Investors

LeanLife Health management can't account for recent market activity

Volumes have increased over the last day or so and the share price is up almost 80% since last Friday (October 5)
LeanLife Health management can't account for recent market activity
Shares have risen in recent days

Nutritional additive and ingredients group LeanLife Health Inc. (CSE:LLP) said it was unaware of any reason behind the recent increase in market activity in the shares.

Volumes have increased over the last day or so and the share price is up almost 80% since last Friday (October 5). It is at $0.09 from $0.05 last week.

"At the request of the Investment Industry Regulatory Organization of Canada, LeanLife Health Inc. wishes to confirm that the company's management is unaware of any material change in the company's operations that would account for the recent increase in market activity," it said in a brief statement Friday.

The company's products are extracted from flax seeds, a source of omega 3. They can be used as a food additive or as a nutraceutical and can be incorporated into foods such as bread, noodles, cheese, yoghurt, juice and milk products.

View full LLP profile View Profile

LeanLife Health Timeline

Newswire
February 07 2019

Related Articles

cancer
February 25 2019
Immunotherapy treatment Clevegen is on phase I/II trial (MATINS) for metastatic tumours
Once the phase III trial is completed, Futura plans to either sell off the asset or find a partner
September 26 2018
The pharma group expects to dose the first patient in the Phase III trial of its MED2002 erectile dysfunction treatment within the next month
lung in x-ray
February 25 2019
The company has been developing a treatment for chronic lung disease in-house and has partnered with an Australian group to develop a drug for rare liver and lung complaints
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use